Related Neuroscientific Initiative

Description

AddNeuroMed

The AddNeuroMed objectives are to:

• Produce improve experimental models of Alzheimer's for biomarker discovery
• Identify a biomarker for Alzheimer's disease suitable for
  • Diagnosis, especially early diagnosis
  • Prediction, in particular helping to identify those people with mild cognitive impairment at increased risk of developing dementia
  • Monitoring disease progression for use in clinical trials and in clinical practice

ADNI

(Alzheimer's Disease Neuroimaging Initiative)

ADNI is a huge project to define the rate of progress of mild cognitive impairment and Alzheimer's disease, to develop improved methods for clinical trials in this area, and to provide a large database which will improve design of treatment trials. It is expected that this project will provide information and methods which will help lead to effective treatments for Alzheimer's disease, leading to effective prevention.

CANet- CANARIE Network

(Canada's Advanced Research and Innovation Network)

CANARIE is a high performance hybrid network that supports data-intensive research and innovation across a range of private and public sector users. This hybrid network infrastructure, equipped with leading-edge optical and routing equipment, enables CANARIE to offer traditional IP network services and Lightpath services while continuing to develop new network service offerings.

CATI

(Centre d' Acquisition et de Traitement Automatise de l'Image)

The Fondation Plan Alzheimer trusted CEA to create a national research centre dedicated to image treatment, the 'Centre d' Acquisition et de Traitement Automatisé de l' Image'. The aim of this centre consists of making available to the scientific and medical community working on AD, the know-how to ensure a centralized treatment of images and processes to extract exploitable knowledge deriving from large volumes of information generated by a network of imaging tools deployed on the French territory.  

CBRAIN

The CBRAIN Project is an initiative to develop a pan-Canadian network of the five leading brain imaging research centres in Canada. The goal of the project is to develop a Canada-wide platform for distributed processing, analysis, exchange and visualisation of brain imaging data. The expected result is a middleware platform that will render the processing environment (hardware, operating systems, storage servers, etc...) transparent to a remote user. The CBRAIN team is developing new techniques for structural and functional brain mapping and applying these techniques to examine normal and pathological changes in brain anatomy.

DECIDE

(Diagnostic Enhancement of Confidence by an International Distributed Environment)

The aim of DECIDE  is to design, implement, and validate a GRID-based e-Infrastructure building upon neuGRID and relying on the Pan-European backbone GEANT and the NRENs. Over this e-Infrastructure, a service will be provided for the computer-aided extraction of diagnostic markers for Alzheimer's disease and schizophrenia from medical images.

EADC

(European Alzheimer's Disease Consortium)

The EADC is a fully functional network of over 50 European centres of clinical and biomedical excellence working in the field of AD. It provides a setting in which to increase the scientific understanding of and to develop ways to prevent, delay, slow or ameliorate the primacy and secondary symptoms of AD.           

EuroBioImaging

Euro‐BioImaging is a large‐scale pan‐European research infrastructure project on the European Strategy Forum on Research Infrastructures (ESFRI) Roadmap. Euro‐BioImaging will deploy a distributed biological and biomedical imaging infrastructure in Europe in a coordinated and harmonized manner. By providing access to and training in imaging technologies and by sharing of best practice and image data, Euro‐BioImaging will become an engine that will drive European innovation in imaging research and technologies.

GAAIN

(Global Alzheimer's Association Interactive Network)
 

Humain Brain Project

The principle goal of the Human Brain Project is to build a European research facility that will simulate the human brain and exploit the results. The Human Brain Project is integrating everything we know about the brain into computer models and using these models to simulate the actual working of the brain. Ultimately, it will attempt to simulate the complete human brain. The models built by the project will cover all the different levels of brain organisation – from individual neurons through to the complete cortex. The goal is to bring about a revolution in neuroscience and medicine and to derive new information technologies directly from the architecture of the brain. The thirteen universities, research institutes and hospitals leading the project will each be responsible for one specific research niche, coordinating the activities of hundreds of other universities and hospitals in Europe and around the world.

LONI

(Laboratory of NeuroImaging)

The UCLA LONI seeks to improve understanding of the brain in health and disease. The laboratory is dedicated to the development of scientific approaches for the comprehensive mapping of the brain structure and function. LONI is a leader in the development of advanced computational algorithms and scientific approaches for the comprehensive and quantitative mapping of brain structure and function.

LSGC

(Life Science Grid Community)

The LSGC serves the worldwide healthcare and life sciences community in its adoption and exploitation of distributed computing infrastructures. The LSGC covers scientific domains such as bioinformatics, genomics, biobanking, medical imaging, statistical analysis, and systems biology. The main objectives are to:

• Represent the life science grid users for the negotiation of resources and to liaise with EGI and other worldwide resource providers.
• Coordinate by serving as a contact point for new users, share expertise to avoid replication of efforts within the community, collect and define domain-specific requirements, and encourage sharing of resources, data and tools.
• Provide technical services, operate and support common VOs and shared services, and provide targeted user support and application porting.
• Organise community-specific training events that can smooth the learning curve and lower start-up costs.
• Disseminate and transfer knowledge, advertise actions, and facilitate communication internally with the members and externally to other groups of interest (e.g., funding and policy-making initiatives).

PharmaCOG

(Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development)

PharmaCog, a partnership of 31 academic and industry actors from 7 countries, co-ordinated by GlaxoSmithKline R&D and the Université de la Méditerranée, started its activities on 1 January 2010 thanks to significant funding  from the Innovative Medicines Initiative. Its launch marks the start of the most ambitious European project for tackling bottlenecks in Alzheimer's disease research and drug discovery. PharmaCog will provide the tools needed to define more precisely the potential of a drug candidate, reduce the development time of new medicines and thus accelerate the approvals of promising new medicines.

SHIWA

(Sharing Interoperable Workflows for large-scale scientific simulations on Available DCIs)

The SHIWA project main goal is to everage existing workflow based solutions and enable cross-workflow and inter-workflow exploitation of DCIs by applying both coarse and fine-grained strategies.The coarse-grained (CG) approach enables to combine workflows written in different workflow languages in order to reuse and combine existing workflow applications written in various workflow languages. The CG approach treats existing workflows as black box systems that can be incorporated into other workflow applications as workflow nodes. The fine-grained approach addresses language interoperability by defining an intermediate representation to be used for translation of workflows across various systems (ASKALON, Pegasus, P-Grade, MOTEUR, Triana).

TEIN

(Trans-Eurasia Information Network)

The third generation TEIN3 provides a dedicated high-capacity Internet network for research and education communities across Asia-Pacific. TEIN3 already connects researchers and academics in China, India, Indonesia, Japan, Korea, Laos, Malaysia, Nepal, Pakistan, the Philippines, Singapore, Sri Lanka, Taiwan, Thailand, Vietnam and Australia. Bangladesh, Bhutan and Cambodia are in the process of getting connected, bringing the total number of partners involved in TEIN3 to 19. With direct connectivity to Europe's GÉANT network, TEIN3 offers Asia-Pacific a gateway for global collaboration, enabling over 45 million users at more than 8000 research and academic centres to participate in joint projects with their peers in Europe and other parts of the world.